The puberty blocker "trial" isn't as a real clinical trial, but rather a way for the medical profession to wash their hands of the children currently taking puberty blockers. 🧵/20
Hilary Cass says there are "no limit" to places for the first phase of a clinical trial. Everyone knows that isn't how clinical trials work. 2/20
There arguably can be "no limit" so that the NHS can shift as many children currently taking puberty blockers onto the "trial". 3/20 nhs.uk/conditions/gen…
These children are clinical negligence claimants, as they have been prescribed puberty blockers with what the Cass Review said was unclear rationale and weak evidence. 4/20
However if they are entered onto the trial, they can become "unfortunate clinical trial outcomes" and the medical profession can wash their hands of them. 5/20
The Cass Review's conclusion that puberty blockers had been prescribed with unclear rationale and weak evidence was also an understatement. 7/20
GIRES had been training the NHS to prescribe puberty blockers to a tomboy who had seen "transgender" on YouTube. 8/20
One trustee of GIRES appears to be a man with autogynephilia, a cohort known to project their belief that they have a "mismatched" "gender identity" or "essence" of the opposite sex onto children, and recommend medical treatments. 9/20bbc.co.uk/news/uk-wales-…
The same thing arguably happened in the United States, where Rachel Levine, former assistant US secretary for health, lobbied to remove minimum age limits for "gender affirming" surgeries: 10/20nytimes.com/2024/06/25/hea…
The Cass Review covered up all the accounts it received of men talking about autogynephilia, marked “strictly confidentially”, “where relevant anonymously”, “not to be shared". 11/20whatdotheyknow.com/request/inform…
Given that the NHS signposts to GIRES in other content, it is arguable that GIRES had an influence on the NHS's page on "gender dysphoria", which bears no resemblance to "gender dysphoria" in the DSM-5 (below). 12/20 nhs.uk/conditions/gen…
Any mention of the different pathways of "gender dysphoria" and autogynephilia have been stripped out, and instead replaced with GIRES's mismatched "gender identity"/"essence"/"soul" narrative for everybody (below). 13/20
I have been asking the NHS since 2022 to fix its page on "gender dysphoria" to resemble what is in the DSM-5 definition of "gender dysphoria". This is now a task from the Cass Review, but they still haven't updated it. 14/20
The medical profession arguably can't update it, as if they update it, the idea that children can have a "mismatched" "gender identity" "essence" of the opposite sex will be shown to be a lie, spoiling the premise of the "trial". 15/20
It appears what the medical profession have done instead, is to shift to "gender incongruence", a definition that also strips out any mention of autogynephilia (this definition was influenced by WPATH, i.e. by men with autogynephilia). 16/20
The "gender incongruence" definition works for both men with autogynephilia and the medical profession, as neither want to tell the truth. The puberty blocker trial uses "gender incongruence": different words for the same "mismatched" "essence" narrative. 17/20
I do not think I am being overly cynical, given the contaminated blood scandal shows the medical profession would absolutely engage in "downright deception", "deliberate concealment" and "not telling people what they had a right to know". 18/20
The medical profession could easily show that I am wrong, by adding a paragraph on autogynephilia to their page on "gender dysphoria", and by saying it is an option for children who were prescribed puberty blockers to sue the NHS. 19/20
I have an objection sitting with the Health Research Authority if the medical profession decide to go ahead with the trial: 20/20transpolicy.substack.com/p/objection-to…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
In 2024, I made a complaint to Action for Children (£155,280,000, 2024) about their content on "gender identity". It went all the way to CEO, Paul Carberry. I was surprised when I later found out that Carberry is a murderer. 🧵/24
In May 2024, I complained to Action for Children that their definition of "gender dysphoria" as being a matter of having a "mismatch[ed] gender identity" was misleading, and targeting this narrative at children was causing a social contagion. 2/24 parents.actionforchildren.org.uk/feelings-behav…
I sent Action for Children a memo discussing the DSM-5, which shows "gender dysphoria" is actually related to atypical sexuality. In most cases children with "early-onset gender dysphoria" grow out of it at the onset of puberty, when they are also likely to be homosexual. 3/24
There are men with autogynephilia, who will undergo surgery to resemble women, so that they can contemplate themselves in the mirror, and be attracted to what they see. 1/5
Men with autogynephilia insist that their motivation is not a paraphilia, but an expression of their internal female "gender identity". This is what the medical profession also now believes... 2/5
... so they are performing surgeries on everyone who claims to have a "mismatched" "gender identity", e.g. "The mothers left distraught after the NHS removed their daughters' healthy breasts because the girls said they were transgender". (Daily Mail). 3/5
I predict the NHS will replace its page on "Gender dysphoria" with "Gender incongruence" this is why. 🧵/18nhs.uk/conditions/gen…
The current NHS England page on "Gender dysphoria" is incorrect. The DSM-5 defines "gender dysphoria" as a matter of atypical sexuality/sexual orientation: "early-onset gender dysphoria" is related to nascent homosexuality and desistence. 2/18
"Late-onset gender dysphoria" is mostly related to an inexplicable male paraphilia, namely "autogynephilia". The DSM-4 notes "gender identity disorder" was something that usually only affected males: boys with "early-onset gender dysphoria" outnumbered girls 5:1... 3/18
The fake "mismatched" "gender identity" narrative has caused a mental health social contagion amongst adolescent girls, which is now resulting in thousands of double mastectomies; an atrocity. The medical profession need to tell the truth about autogynephilia. 🧵/24
The narrative targeted at the public and children is that there are a class of "trans" people, even children, who have some internal "essence" or "gender identity" that has "mismatched". This is also the premise that the medical profession is using to prescribe treatments. 2/24
This isn't the truth about what the DSM says about "gender dysphoria", where the concept is first defined. Women and girls never used to be greatly represented as having "gender identity" disorder. Boys outnumbered girls 5:1. Men 2 or 3 times to 1. 3/24
The Cass Review should have ended the "gender identity" scandal in 2024, but the medical profession did the same as with contaminated blood: it "[hid] the truth" by telling "half truths", "deliberate concealment" and not "telling people what they had a right to know". 1/37
The Cass Review uses the term "gender dysphoria" from the DSM-5 but doesn't explain fully what it is; it told a half truth. 2/37
The DSM-5 divides "gender dysphoria" into two types: "early-onset" and "late-onset", and shows "gender dysphoria" is connected to atypical sexual orientation. "Early-onset gender dysphoria" usually desists at the onset of puberty and is related to nascent homosexuality. 3/37
Young Minds (£7,6million, 2024) removes content targeted at children, saying "[puberty blockers] give you more time to explore your gender identity". This new content was published even after the Cass Review and UK government ban. 1/26
In April 2024, the Cass Review found that the "rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria... The effect on cognitive and psychosexual development remains unknown." 2/26
Despite this, Stonewall and GIRES have not updated their content promoting puberty blockers. GIRES and Young Minds have even issued new content, that is unsubstantiated by evidence. The Charity Commission sit back, despite complaints. 3/26